The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Performance of a targeted methylation-based multi-cancer early detection test by race/ethnicity.
 
Wai Hong Wilson Tang
Honoraria - American Board of Internal Medicine (ABIM); Springer Nature
Consulting or Advisory Role - Cardiol Therapeutics; Owkin; PreCardia; Relypsa; Sequana Medical
Research Funding - 3ive Labs; Alnylam; Applied DNA Sciences; Pfizer; Salubris Biotherapeutics
Other Relationship - Cardiac Community Core Lab (I)
 
Habte Aragaw Yimer
Consulting or Advisory Role - Amgen; Celgene; Epizyme; Seagen
Speakers' Bureau - AstraZeneca; Janssen
 
Mohan K. Tummala
No Relationships to Disclose
 
Spencer Shao
Employment - Compass Oncology
 
Gina G. Chung
No Relationships to Disclose
 
Jessica M. Clement
Employment - eviCore healthcare (I)
Consulting or Advisory Role - Anthem
Travel, Accommodations, Expenses - Anthem
 
Jingjing Gao
Employment - GRAIL
Stock and Other Ownership Interests - Abbvie; Gilead Sciences; GRAIL
 
Earl Hubbell
Employment - GRAIL
Stock and Other Ownership Interests - GRAIL
Patents, Royalties, Other Intellectual Property - GRAIL
 
Kathryn Kurtzman
Stock and Other Ownership Interests - GRAIL; Illumina
 
Charles Swanton
Stock and Other Ownership Interests - Achilles Therapeutics; Apogen Biotechnologies; Epic Sciences; GRAIL
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Illumina; Lilly; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche
Consulting or Advisory Role - Bicycle Therapeutics; Genentech/Roche; Medicxi; Sarah Cannon Research Institute
Research Funding - Archer; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Ono Pharmaceutical; Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Founder of Achilles Therapeutics: a biotechnology company funded by Syncona/Wellcome Trust to target clonal Neoantigens through vaccine and cell therapy approaches; Immune checkpoint intervention in cancer (PCT/EP2016/071471),; Method for determining whether an HLA allele is lost in a tumour (PCT/GB2018/052004); Method for identifying responders to cancer treatment (PCT/GB2018/)051912); Method for treating cancer (PCT/EP2016/059401).; Method for treating cancer based on identification of clonal neo-antigens (PCT/EP2016/059401); Method of detecting tumour recurrence (PCT/GB2017/053289); Method of identifying insertion/deletion mutation targets (PCT/GB2018/051892); Method of predicting survival rates for cancer patients (PCT/GB2020/050221); Method of treating cancer by targeting insertion/deletion mutations (PCT/GB2018/051893); Methods for lung cancer detection (PCT/US2017/028013)
(OPTIONAL) Uncompensated Relationships - AstraZeneca (Inst)
 
Lewis R. Roberts
Consulting or Advisory Role - Bayer (Inst); Biocompatibles (Inst); Exact Sciences (Inst); GRAIL (Inst); QED Therapeutics (Inst); RedHill Biopharma (Inst); TAVEC (Inst)
Speakers' Bureau - Bayer
Research Funding - ARIAD (Inst); BTG (Inst); Exact Sciences (Inst); Gilead Sciences (Inst); Glycotest (Inst); RedHill Biopharma (Inst); Wako Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - Five Prime Therapeutics. Royalties (Inst); Five Prime Therapeutics. Royalties.; US Patent No. 9,469,877: Materials and Methods for Diagnosis, Prognosis, Monitoring of Recurrence and Assessment of Therapeutic/Prophylactic Treatment of Pancreaticobiliary Cancer (Inst)
Travel, Accommodations, Expenses - Gilead Sciences